Cost-Utility Analysis of Sacituzumab Tirumotecan for the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer

PAN Min, GE Kunkun, JU Wenxiang, ZHU Tongming, SHEN Aizong

Herald of Medicine ›› 2026, Vol. 45 ›› Issue (8) : 1439-1446.

PDF(1847 KB)
中国科技论文统计源期刊　中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库（JST）
第七届湖北十大名刊提名奖  
PDF(1847 KB)
Herald of Medicine ›› 2026, Vol. 45 ›› Issue (8) : 1439-1446. DOI: 10.3870/j.issn.1004-0781.2026.08.019

Cost-Utility Analysis of Sacituzumab Tirumotecan for the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 45(8): 1439-1446 https://doi.org/10.3870/j.issn.1004-0781.2026.08.019

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1847 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉